Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MIT Holding Inc MITD

"MIT Holding Inc provides intravenous therapies to patients at their homes in the United States. Further through its affiliations and contractors, the company prepares intravenous medication for home infusion by the patient, administers intravenous infusions, provides medical management services, the ambulatory center where therapies are administered and sells and rents home medical equipment... see more

GREY:MITD - Post Discussion

MIT Holding Inc > 14-page MITD Investor Relations Kit is Now Available Online
View:
Post by qualitystocks.net on Feb 04, 2015 3:54pm

14-page MITD Investor Relations Kit is Now Available Online

14-page MITD Investor Relations Kit is Now Available Online
 
https://mitd.qualitystocks.net/ir/
 
Please see disclaimer on the QualityStocks website: https://Disclaimer.QualityStocks.com
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities